Neurol. praxi. 2018;19(3):183-186 | DOI: 10.36290/neu.2018.094

Focal forms of acute polyradiculoneuritis

doc. MUDr. Edvard Ehler, CSc.
Neurologická klinicka FZS Univerzita Pardubice, Pardubická krajská nemocnice, Pardubice

Acute polyradiculoneuritis (Guillain-Barré syndrome – GBS) is a multifocal autoimmune form of neuropathy. This neuropathy has its classicalforms – acute inflammatory demyelinating polyradiculoneuritis (AIDP) affects myelin sheath and primary axonal form is characterizedby pure motor disorder AMAN or severe mixed sensory-motor form AMSAN. Among the variants or focal forms can be differentiatedMiller-Fisher syndrome with clinical trias – ophthalmoplegia, ataxia and areflexia – and pharyngo-cervico-brachial form with dysphagia,weakness of neck and brachial muscles. Besides these two most frequent variants there some other forms – Bickerstaff brainstemencephalitis, paraparetic form of GBS (Guillain-Barré syndrome), cranial neuropathies, acute pandysautonomia, pure sensory form ofGBS. The individual variants are charactrized by clinical symptoms, the course, by abnormal neurophysiological investigations, therapy.

Keywords: acute polyradiculoneuritis, autoimmune inflammation, electromyography, immunological therapy

Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E. Focal forms of acute polyradiculoneuritis. Neurol. praxi. 2018;19(3):183-186. doi: 10.36290/neu.2018.094.
Download citation

References

  1. Ambler Z. Poruchy periferních nervů. Praha: Triton. 2013.
  2. Amato AA, Russel JA. Neuromuscular disorders. New York: McGraw Hill Medical, 2008.
  3. Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin 2013; 31: 491-510. Go to original source... Go to PubMed...
  4. Han C, Wang Y, Jia J, Ji X, Frederickson V, Ding Y, Sun W, Xu J, Sun YX. Bickerstaff brainstem encefalitis, Miller-Fisher syndrome and Guillain-Barré syndrome overlap in an asthma patient with negative anti-ganglioside antibodies. BMS Research Notes 2012; 5: 295-301. Go to original source... Go to PubMed...
  5. Katirji B, Kaminski HJ, Ruff RL. Neuromuscular disorders in clinical practice. Springer New York, 2014. Go to original source...
  6. Kuwabara S, Missawa S, Takahashi H, Sawai S, Kanai K, Nakata M, Mori M, Hattori T, Yuki N. Anti-GQ1 antibody does not affect neuromuscular transmission in human limb muscle. J Neuroimmunol 2007; 189(1-2): 158-162. Go to original source... Go to PubMed...
  7. Kuwabara S, Sekiguchi Y, Misawa S. Electrophysiology in Fisher syndrome. Clin Neurophysiol 2017; 128(1): 215-219. Go to original source...
  8. Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, Sonoo M, Takada K and the Japanese GBS Study Group. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes. J Neurol Neursurg Psychiatry 2015; 86: 110-114. Go to original source...
  9. Mori M, Kuwabara S, Yuki N. Fisher syndrome: clinical features, immunopathogenesis and management. Exper Rev Neurother 2012; 12(1): 39-51. Go to original source... Go to PubMed...
  10. Pourmand R. Immune-mediated neuromuscular diseases. Basel: Karger, 2009 Go to original source...
  11. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barré syndrome: A critical revision and a need for an update. Clinical neurophysiology 2012; 123: 1487-1495. Go to original source... Go to PubMed...
  12. Wakerley BR, Yuki N. Pharyngo-cervico-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2014; 85: 339-344. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.